These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8813946)

  • 21. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Overexpression of differentiation inhibitory factor/nm23 in acute myeloid leukemia].
    Kado J; Yokoyama A
    Rinsho Ketsueki; 1998 Feb; 39(2):92-4. PubMed ID: 9545807
    [No Abstract]   [Full Text] [Related]  

  • 23. [Expression of metastasis suppressor gene nm23-H1 in oral squamous cell carcinoma and its relation to tumor prognosis].
    Zhang T; Lai Q; Du D
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):292-4. PubMed ID: 11776896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NM23-H1 and NM23-H2 gene expression in human renal tumors.
    Theisinger B; Engel M; Seifert M; Seitz G; Welter C
    Anticancer Res; 1998; 18(2A):1185-9. PubMed ID: 9615786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoreactivity of nm23-H1 protein in renal cell carcinoma.
    Kuo JY; Chang KM; Chen KK; Chang LS
    Anticancer Res; 1998; 18(1B):531-6. PubMed ID: 9568173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of nm23 in melanoma progression and its prognostic significance.
    Betke H; Korabiowska M; Brinck U; Trybus-Gałuszka H; Kellner S; Okoń K; Stachura J; Droese M
    Pol J Pathol; 1998; 49(2):93-6. PubMed ID: 9798412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoskeletal association of the A and B nucleoside diphosphate kinases of interphasic but not mitotic human carcinoma cell lines: specific nuclear localization of the B subunit.
    Pinon VP; Millot G; Munier A; Vassy J; Linares-Cruz G; Capeau J; Calvo F; Lacombe ML
    Exp Cell Res; 1999 Feb; 246(2):355-67. PubMed ID: 9925751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of the promoter for the human metastasis suppressor gene nm23-H1.
    de la Rosa A; Mikhak B; Steeg PS
    Arch Med Res; 1996; 27(3):395-401. PubMed ID: 8854401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
    Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
    Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
    Iizuka N; Hirose K; Noma T; Hazama S; Tangoku A; Hayashi H; Abe T; Yamamoto K; Oka M
    Br J Cancer; 1999 Oct; 81(3):469-75. PubMed ID: 10507772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.
    Miyazaki H; Fukuda M; Ishijima Y; Takagi Y; Iimura T; Negishi A; Hirayama R; Ishikawa N; Amagasa T; Kimura N
    Clin Cancer Res; 1999 Dec; 5(12):4301-7. PubMed ID: 10632374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the tumor metastasis suppressor Nm23-H1/Nm23-R1 as a constituent of the centrosome.
    Roymans D; Vissenberg K; De Jonghe C; Willems R; Engler G; Kimura N; Grobben B; Claes P; Verbelen JP; Van Broeckhoven C; Slegers H
    Exp Cell Res; 2001 Jan; 262(2):145-53. PubMed ID: 11139339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nm23 and cathepsin D expression in laryngeal carcinomas.
    Hadice Elif Pestereli ; Gulay Ozbilim ; Ozlem Elpek ; Firat Fisenk ; Esor Balkan
    Adv Clin Path; 2000 Jul; 4(3):121-5. PubMed ID: 11080791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Low expression of nm23-H1 mRNA and its protein in breast cancer].
    Guo W; Wang Y; Zhuang X; Bai Y; Zhang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):91-3. PubMed ID: 10751528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23.
    Ohkura N; Kishi M; Tsukada T; Yamaguchi K
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1206-10. PubMed ID: 11302744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [CD44v and nm23-H1 gene product expression and its clinical significance in human recurrent bladder cancer].
    Li B; Li Y; Dai Q; Zhu J; Jia J
    Zhonghua Wai Ke Za Zhi; 1998 May; 36(5):312-3. PubMed ID: 11825398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ki67, p53, nm23, and DNA cytometry in bladder cancer: potential markers for detection of recurrence?
    Feil G; Krause FS; Zumbraegel A; Wechsel HW; Bichler KH
    Adv Exp Med Biol; 2003; 539(Pt A):99-109. PubMed ID: 15088899
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of the prognostic significance of nm23/NDP kinase and cathepsin D in anal carcinomas. An immunohistochemical study.
    Holm R; Tanum G
    Virchows Arch; 1996 May; 428(2):85-9. PubMed ID: 8925129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nm23--into the basement (membrane).
    Myeroff LL; Markowitz SD
    J Natl Cancer Inst; 1994 Dec; 86(24):1815-7. PubMed ID: 7990152
    [No Abstract]   [Full Text] [Related]  

  • 40. Urothelial differentiation and bladder cancer.
    Liebert M; Gebhardt D; Wood C; Chen IL; Ellard J; Amancio D; Grossman HB
    Adv Exp Med Biol; 1999; 462():437-48. PubMed ID: 10599446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.